NASH – Liver Disease

Current Studies:

Call 515-225-6050 to discuss which study might be right for you or fill out a personal contact form.


Support Resources:

https://www.inspire.com/groups/american-liver-foundation/

https://www.drugs.com/answers/support-group/nonalcoholic-fatty-liver-disease/


What is NASH?

NASH is an acronym that stands for Non-Alcoholic SteatoHepatitis. It is the most severe form of non-alcoholic fatty liver disease (NAFLD), and is characterized by the presence of an abnormal accumulation of fat in the liver which in some individuals can progress to liver cell injury (hepatocellular ballooning) and inflammation. Hepatocellular ballooning and inflammation – sometimes called necroinflammation – are commonly considered as the drivers of disease progression, or as the underlying causes of the disease. As NASH evolves, over time it can result in excessive scarring in the liver (fibrosis), a natural response to injury which can lead to liver cirrhosis or liver cancer.

 

Source: 2018 The NASH Education ProgramTM  https://www.the-nash-education-program.com/what-is-nash/